Park Ha Biological Technology Stock (NYSE:PHH)
Previous Close
$20.48
52W Range
$3.70 - $21.11
50D Avg
$14.41
200D Avg
$10.14
Market Cap
$497.42M
Avg Vol (3M)
$397.66K
Beta
-0.02
Div Yield
-
PHH Company Profile
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.